Tradestie Institutional Equity Comparison Engine

SLN vs NBP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NBP Overall Edge

NBP Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NBP (NBP) driven by superior Valuation, Growth & Margin while SLN counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, SLN trades at N/M Forward P/E with -10475.6% operating margin (+197.2% YoY revenue) versus NBP at 2.7x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SLN sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against NBP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner NBP
SLN N/M vs NBP 2.7x Fwd P/E
Growth & Margin Winner NBP
Op Margin -10475.6% vs 0.0% ยท YoY +197.2% vs +0.0%
Momentum & Technical Winner SLN
1Y +186.3% vs -81.0% ยท 52W Pos 100% vs 0%
Options & Structure Winner SLN
UNCLASSIFIED (50th %ile IV) vs UNCLASSIFIED (N/A IV)
SLN NASDAQ
Silence Therapeutics Plc American Depository Share
Pharmaceutical Preparations
$19.82
-0.08% 1D
Market Cap $1.2B
1M Return +128.28%
1Y Return +186.34%
Forward P/E N/M
Unified AI Score
46.9 / 100 HOLD
Tech 24.0 Fund 34.0 Flow 50.0 Mom 30.0
NBP US Equity
NBP
Institutional Equity
$0.79
-6.66% 1D
Market Cap $96.3M
1M Return -37.04%
1Y Return -80.98%
Forward P/E 2.7x
Unified AI Score
51.9 / 100 HOLD
Tech 60.0 Fund 50.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SLN +186.34% NBP -80.98% Spread: +267.32 pp (SLN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SLN TTM Op. Margin: -10475.6% NBP TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SLN vs NBP. Trailing 12-month operating profitability (SLN -10475.6% vs NBP 0.0%) and valuation multiples (SLN N/M vs NBP 2.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SLN (4) vs NBP (5)
Institutional Metric SLN NBP Criterion Row Winner
Market Capitalization Scale $1.2B $96.3M Larger Scale SLN
Trailing P/E Ratio Valuation N/M 2.7x Lower Multiple NBP
Forward P/E Ratio Valuation N/M 2.7x Lower Multiple NBP
Revenue Growth (YoY) Growth +197.2% +0.0% Higher Growth SLN
Operating Margin (TTM) Profitability -10475.6% 0.0% Higher Margin NBP
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -90.4% -59.1% Higher ROE NBP
52-Week Range Position Momentum 100% ($4โ€“$20) 0% ($1โ€“$5) Stronger Trend SLN
Beta / 30D Volatility Risk Regime 1.92ฮฒ ยท 4% Vol 1.66ฮฒ ยท 81% Vol Lower Realized Risk SLN
Unified Institutional Score Composite Signal 46.9 / 100 (HOLD) 51.9 / 100 (HOLD) Higher Composite NBP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SLN vs NBP Buy Guide
SLN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SLN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NBP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NBP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SLN nor NBP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.